Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo: To conduct basic and translational studies on ApoE2 and other variants to improve understanding of physiologic and cellular differences attributable to the ApoE e2 allele (vs. other ApoE alleles), and how they mediate ApoE e2’s differential effects on longevity and risk for age-related conditions.  This will aid in the identification of potential therapeutic targets for interventions that prevent or ameliorate aging-related diseases by mimicking favorable differential effects of the ApoE e2 variant, while avoiding adverse effects.

Inscrições: até 16 de fevereiro de 2018

Mais informações em R01 e R21.

Objetivo: To award an individual for dedicated and exceptional researchs with contributions to the reduction of risks to foodborne illness.

Inscrições: até 20 de fevereiro de 2018

Mais informações no site.

Objetivo: To encourage applications from the scientific community to support outstanding research in the area of oocyte mitochondrial function in relation to fertility, aging, and mitochondrial disease transmission to offspring. The overarching goal is to gain fundamental insight into the role of mitochondria and long-term consequences of their dysfunction in the oocyte, and to develop therapeutic or alternative approaches to treat mitochondrial dysfunction for improving oocyte quality and competency, and health of the resultant offspring.

Inscrições: até 16 de fevereiro de 2018

Mais informações em R01 e R21.

Objetivo: To support meritorious research projects that conduct secondary data analyses of these FaceBase datasets relevant to craniofacial development, human craniofacial conditions or traits, and animal models of those craniofacial conditions. Informatics projects that integrate data from multiple FaceBase datasets are especially encouraged.

Inscrições: até 16 de fevereiro de 2018

Mais informações no site.

Objetivo: The purpose of this Funding Opportunity Announcement (FOA) is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as 1) pathogenesis, 2) host response, 3) disease transmission, 4) vector biology and natural history, 5) vaccines, 6) diagnostics, and 7) therapeutics.

Inscrições: até 16 de fevereiro de 2018

Mais informações em R01 e R21.

Objetivo: This Funding Opportunity Announcement (FOA) invites applications that propose basic, clinical, or translational research on non-healing ulcerative wounds and their consequences in aging and in older persons. Applications are solicited which focus on the 1) biology, etiology and pathophysiology of non-healing ulcerative wounds in animal models and/or older adults; 2) translation of basic/clinical research into clinical practice and health decision-making; 3) diagnosis, prevention, management and clinical outcomes of non-healing wounds in older adults.

Inscrições: até 16 de fevereiro de 2018

Mais informações em R01 e R21.

Objetivo: The NINDS Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects, which fall within the mission of the NINDS. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience, or to the development of novel techniques, agents, methodologies, or models, of high value to the neuroscience community.

Inscrições: até 16 de fevereiro de 2018

Mais informações no site.

Objetivo: The UN Climate Resilience Initiative A2R: Anticipate, Absorb, Reshape is a global multi-stakeholder initiative launched by the former UN Secretary General Ban Ki-moon during COP21 in Paris. The Initiative strengthens climate resilience for most vulnerable countries and people and brings together governments, international agencies, regional initiatives, the private sector, civil society and academia.

Inscrições: até 11 de fevereiro de 2018

Mais informações no site.

Objetivo: The goal of this FOA is to accelerate and improve the preclinical testing of candidate treatments and therapeutic compounds in order to move promising new drug therapies into clinical trials.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Objetivo: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.